tirzepatide and zepbound Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity Zepbound beats Wegovy for weight

Botulinum toxin type A, by contrast, acts locally at injection sites to temporarily reduce muscle activity and smooth wrinkles

This narrative review synthesizes preclinical, clinical, and real-world evidence evaluating the therapeutic potential of GLP-1RAs in BD

For most adults seeking growth hormone improvement, sermorelin has a more favorable safety profile than exogenous HGH

the compound's evidence base is limited to preclinical in vitro and animal (largely rodent) studies of IGF-1 receptor activation, muscle-cell signaling, and tissue repair, with human safety and efficacy data for this specific analog effectively absent